2nd ECP Summer Summit at Henkel HQ, Düsseldorf290 participants from 18 nations at the late summer edition of the European Chemistry Partnering in Düsseldorf High level or participation from Southern and Eastern EuropeAttendance record and more … more ➔
Gut bacterial enzyme keeps inflammation awayAn antimicrobial molecule produced by the human microbiota gut may help fight drug-resistant infections. more ➔
Tacalyx GmbH raises €7m in seed fundingGerman Tacalyx GmbH has baged €7m in seed financing to generate antibodies that home in on tumour-antigene specific carbohydrates (TACAs) of glycans. more ➔
Evotec and Takeda enter drug discovery dealEvotec SE and Takeda Pharmaceutical Company Ltd have entered a strategic drug discovery collaboration potentially worth $850m. Under the agreement, Evotec will develop at least five small molecule discovery … more ➔
EMA greenlights new medicinesAt its September meeting, the EMA’s CHMP recommended three innovative medicines for EU market approval. more ➔
New malaria lead kills 99.9% of pathogensDutch and US researchers have re-engineered non-druggable compounds that block the transmission and metabolism of the malaria parasite Plasmodium falciparum. more ➔
Versantis raises CHF16m in Series B financingSwiss Versantis AG has raised money in order to advance its liver detoxifying candidate VS-01 from ongoing Phase Ia trials to initial Phase IIa efficacy proof. more ➔
Lundback swallows migraine drug maker AlderDanish Lundbeck AS is has secured a stake in the migraine market by paying US$1.95bn (€1.76bn) to acquire Alder BioPharmaceuticals Inc. more ➔
PFF Group NV acquires stake in Autolus TherapeuticsPrague-based PPF Group has acquired a 19.2% stake in Autolus Therapeutics plc, a developer of T cell cancer therapies. more ➔
Researchers identify CTLA-4 response markerGerman and US researchers have found a biomarker that identifies tumours responding to CTLA-4 checkpoint blockers. more ➔
